Gemzar

Gemcitabine Hydrochloride

7.6 High risk

Gemzar & Malignant neoplasm progression

11.9%

of users reported Malignant neoplasm progression

50.2%

also reported Severe reaction

53.0%

are women

Most common medical consequences

Severe reaction

50.2%

Death

44.1%

Hospitalization

5.6%

Have you experienced any negative side effects from this medication?

Gemzar: general information

Most common side effects (58)

Most commonly affected ages

40 - 49 years

9.1%

50 - 59 years

23.2%

60 - 69 years

35.1%

70 - 79 years

28.3%

80 - 89 years

4.3%

On this page